{
    "2018-10-03": [
        [
            {
                "time": "2023-10-01",
                "original_text": "Companies Lure New Workers With College Coaching, Student Debt Repayment",
                "features": {
                    "keywords": [
                        "Companies",
                        "Lure",
                        "Workers",
                        "College Coaching",
                        "Student Debt Repayment"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "education",
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Abbott's CE Mark for FreeStyle Libre 2 Boosts Diabetes Arm",
                "features": {
                    "keywords": [
                        "Abbott",
                        "CE Mark",
                        "FreeStyle Libre 2",
                        "Diabetes"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "medical devices"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Notable ETF Inflow Detected - SPYG, ABT, INTC, PFE",
                "features": {
                    "keywords": [
                        "ETF Inflow",
                        "SPYG",
                        "ABT",
                        "INTC",
                        "PFE"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "financials",
                        "technology",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Abbott's CE Mark for FreeStyle Libre 2 Boosts Diabetes Arm",
                "features": {
                    "keywords": [
                        "Abbott",
                        "CE Mark",
                        "FreeStyle Libre 2",
                        "Diabetes"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "medical devices"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Ionis Pharmaceuticalsâ€™ Valuations on September 28",
                "features": {
                    "keywords": [
                        "Ionis Pharmaceuticals",
                        "Valuations",
                        "September 28"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}